银丹心脑通软胶囊对2型糖尿病患者血小板活化因子、血液流变学和血管内皮细胞功能的影响

    Effects of Yindan Xinnaotong Capsule on Platelet Activating Factors, Blood Rheology and Endothelial Function in Patients with Type 2 Diabetes Mellitus

    • 摘要: 目的 探讨银丹心脑通软胶囊对2型糖尿病患者血小板活化因子、血液流变学和血管内皮细胞功能的影响。方法 按随机数字表法将104例2型糖尿病患者分成对照组(51例)及治疗组(53例)。2组均控制饮食等基础上给予降糖治疗,使血糖持续达标,治疗组在此基础上加用银丹心脑通软胶囊(每次1.2 g,3次·d-1)连续治疗12周。比较2组患者治疗前后血小板膜糖蛋白PAC-1、CD62p表达,血液流变学指标和血浆NO、ET-1水平的变化。结果 与治疗前比较,治疗后,治疗组血小板膜糖蛋白PAC-1、CD62p和血液流变学各项指标及血浆ET-1均明显下降(P<0.05),血浆NO显著升高(P<0.05),且明显优于对照组治疗后(P<0.05);而对照组治疗前后上述指标变化不显著。结论 银丹心脑通软胶囊可以抑制血小板活化,降低血液黏稠度,升高NO和降低ET-1的水平,从而改善糖尿病患者血管内皮细胞功能。

       

      Abstract: OBJECTIVE To investigate the effects of Yindan Xinnaotong capsule on platelet activating factors, blood rheology and endothelial function in patients with type 2 diabetes mellitus. METHODS A total of 104 patients with type 2 diabetes mellitus were randomly arranged into the two groups, receiving glucose-lowing drug only(control group, 51 cases) or glucose-lowing drug plus with Yindan Xinnaotong capsule(treatment group, 53 cases) respectively. The therapeutic course for all were 12 weeks. The expression of membrane glycoprotein PAC-1 and CD62p, the parameters of blood rheology, NO and ET-1 were detected in 2 groups before and after treatment. RESULTS Compared with before treatment, the expression of platelet membrane glycoprotein PAC-1 and CD62p, the parameters of blood rheology and ET-1 were significantly lower (P<0.05), NO were significantly higher in the treatment group(P<0.05), meanwhile the changes of datas in the treatment group were more significantly than those in the control group(P<0.05). There was no significant differences of datas between before and after treatment in control group. CONCLUSION Yindan Xinnaotong capsule can decrease the platelet activation, blood viscosity, ET-1 and imcrease NO, and also improve the vascular endothelial function in patients with type 2 diabetes mellitus.

       

    /

    返回文章
    返回